Biphasic mechanosensitivity of T cell receptor-mediated spreading of lymphocytes.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
26 03 2019
Historique:
pubmed: 10 3 2019
medline: 17 5 2019
entrez: 10 3 2019
Statut: ppublish

Résumé

Mechanosensing by T cells through the T cell receptor (TCR) is at the heart of immune recognition. While the mechanobiology of the TCR at the molecular level is increasingly well documented, its link to cell-scale response is poorly understood. Here we explore T cell spreading response as a function of substrate rigidity and show that remarkably, depending on the surface receptors stimulated, the cellular response may be either biphasic or monotonous. When adhering solely via the TCR complex, T cells respond to environmental stiffness in an unusual fashion, attaining maximal spreading on an optimal substrate stiffness comparable to that of professional antigen-presenting cells. However, in the presence of additional ligands for the integrin LFA-1, this biphasic response is abrogated and the cell spreading increases monotonously with stiffness up to a saturation value. This ligand-specific mechanosensing is effected through an actin-polymerization-dependent mechanism. We construct a mesoscale semianalytical model based on force-dependent bond rupture and show that cell-scale biphasic or monotonous behavior emerges from molecular parameters. As the substrate stiffness is increased, there is a competition between increasing effective stiffness of the bonds, which leads to increased cell spreading and increasing bond breakage, which leads to decreased spreading. We hypothesize that the link between actin and the receptors (TCR or LFA-1), rather than the ligand/receptor linkage, is the site of this mechanosensing.

Identifiants

pubmed: 30850545
pii: 1811516116
doi: 10.1073/pnas.1811516116
pmc: PMC6442626
doi:

Substances chimiques

Ligands 0
Receptors, Antigen, T-Cell 0
Myosins EC 3.6.4.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5908-5913

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Science. 1999 Jul 9;285(5425):221-7
pubmed: 10398592
J Cell Physiol. 2005 Jul;204(1):198-209
pubmed: 15669099
Science. 2005 Nov 18;310(5751):1139-43
pubmed: 16293750
Nat Rev Mol Cell Biol. 2006 Apr;7(4):265-75
pubmed: 16607289
Cell. 2006 Aug 25;126(4):677-89
pubmed: 16923388
Biophys J. 2007 Dec 15;93(12):4453-61
pubmed: 18045965
J Theor Biol. 1991 May 21;150(2):193-200
pubmed: 1832473
Science. 2008 Dec 12;322(5908):1687-91
pubmed: 19074349
Cell Adh Migr. 2008 Apr-May;2(2):95-105
pubmed: 19262096
Cell Motil Cytoskeleton. 2009 Jun;66(6):328-41
pubmed: 19373775
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12729-34
pubmed: 19622735
Nat Phys. 2010 Jun 1;6(6):468-473
pubmed: 20563235
Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a002444
pubmed: 20702599
J Immunol Methods. 2011 Feb 1;364(1-2):33-9
pubmed: 21036178
Biophys J. 2011 Mar 2;100(5):L25-7
pubmed: 21354386
PLoS One. 2011 May 10;6(5):e19680
pubmed: 21572959
PLoS One. 2011;6(7):e22344
pubmed: 21799834
Curr Opin Cell Biol. 2012 Feb;24(1):107-15
pubmed: 22129583
Biophys J. 2012 Jan 18;102(2):248-57
pubmed: 22339861
Biophys J. 2012 Jan 18;102(2):L5-7
pubmed: 22339876
PLoS One. 2012;7(2):e32398
pubmed: 22384241
Nat Mater. 2012 May 27;11(7):642-9
pubmed: 22635042
J Immunol. 2012 Aug 1;189(3):1330-9
pubmed: 22732590
Biophys J. 2013 Aug 6;105(3):581-92
pubmed: 23931306
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2241-6
pubmed: 24469820
Cell. 2014 Apr 10;157(2):357-368
pubmed: 24725404
Nat Mater. 2014 Oct;13(10):979-87
pubmed: 25108614
Biophys J. 2014 Dec 2;107(11):2629-38
pubmed: 25468342
Mol Biol Cell. 2015 Feb 15;26(4):685-95
pubmed: 25518938
Eur J Immunol. 2015 Jun;45(6):1635-42
pubmed: 25782169
Biophys J. 2015 May 5;108(9):2181-90
pubmed: 25954876
Integr Biol (Camb). 2015 Oct;7(10):1272-84
pubmed: 26156536
Integr Biol (Camb). 2016 Mar 14;8(3):287-301
pubmed: 26887857
Nat Cell Biol. 2016 May;18(5):540-8
pubmed: 27065098
J Cell Biol. 2016 Jun 6;213(5):535-42
pubmed: 27241914
Nano Lett. 2017 Jul 12;17(7):4284-4290
pubmed: 28580787
Elife. 2017 Jun 08;6:
pubmed: 28594327
PLoS One. 2017 Aug 17;12(8):e0183174
pubmed: 28817635
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2646-2651
pubmed: 29487208
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2686-E2695
pubmed: 29507238
Front Immunol. 2018 Sep 18;9:2085
pubmed: 30279692
Science. 1978 May 12;200(4342):618-27
pubmed: 347575

Auteurs

Astrid Wahl (A)

Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), CNRS, Aix Marseille University, 13009 Marseille, France.

Céline Dinet (C)

Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), CNRS, Aix Marseille University, 13009 Marseille, France.

Pierre Dillard (P)

Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), CNRS, Aix Marseille University, 13009 Marseille, France.
Laboratory Adhesion Inflammation, INSERM, CNRS, Aix Marseille University, 13009 Marseille, France.

Aya Nassereddine (A)

Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), CNRS, Aix Marseille University, 13009 Marseille, France.
Laboratory Adhesion Inflammation, INSERM, CNRS, Aix Marseille University, 13009 Marseille, France.

Pierre-Henri Puech (PH)

Laboratory Adhesion Inflammation, INSERM, CNRS, Aix Marseille University, 13009 Marseille, France.

Laurent Limozin (L)

Laboratory Adhesion Inflammation, INSERM, CNRS, Aix Marseille University, 13009 Marseille, France sengupta@cinam.univ-mrs.fr laurent.limozin@inserm.fr.

Kheya Sengupta (K)

Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), CNRS, Aix Marseille University, 13009 Marseille, France; sengupta@cinam.univ-mrs.fr laurent.limozin@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH